Concurrent injection of cold antibody allows PET imaging of orthotopic pancreatic tumor with "Cu -labeled anti -PD-L1

被引：0

作者：

Wen, Xiaoxia ^{[3
]}

Zhao, Jun ^{[3
]}

Wen, Xiaofei ^{[1
]}

Shi, Sixiang ^{[3
]}

Li, Tingting ^{[2
]}

Li, Chun ^{[3
]}

机构：

[1] Harbin Med Univ, Hosp 4, Harbin, Heilongjiang, Peoples R China

[2] Univ Elect Sci & Technol China, Chengdu, Sichuan, Peoples R China

[3] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

来源：

JOURNAL OF NUCLEAR MEDICINE | 2019年 / 60卷

关键词：

D O I：

暂无

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

607

引用

页数：1

共 50 条

[41] Pet imaging with Cu-64 labeled humanized anti-CEA antibody
Shively, John E.
Bading, James
Colcher, David
Raubitschek, Andrew
TUMOR BIOLOGY, 2007, 28 : 72 - 72
[42] High-Resolution PET Imaging with Therapeutic Antibody-based PD-1/PD-L1 Checkpoint Tracers
Hettich, Michael
Braun, Friederike
Bartholomae, Mark D.
Schirmbeck, Reinhold
Niedermann, Gabriele
THERANOSTICS, 2016, 6 (10): : 1629 - 1640
[43] PET-Imaging of PD-L1 expression for immunotherapy monitoring
Stadlbauer, Sven
Schaefer, Martin
Bauder-Wuest, Ulrike
Kopka, Klaus
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2019, 62 : S263 - S264
[44] A fully human monoclonal antibody targeting PD-L1 with potent anti-tumor activity
Luan, Yan
Chai, Dafei
Peng, Jianjian
Ma, Shuli
Wang, Min
Ma, Hui
Li, Xiang
Fu, Shilong
Pan, Xiaolong
Wang, Xiaoxiao
Qin, Songbing
Xu, Ting
INTERNATIONAL IMMUNOPHARMACOLOGY, 2016, 31 : 248 - 256
[45] A Novel Bispecific Antibody Targeting PD-L1 and VEGF With Combined Anti-Tumor Activities
Cui, Xiaopei
Jia, Huifeng
Xin, Hong
Zhang, Lei
Chen, Shi
Xia, Simin
Li, Xue
Xu, Wei
Chen, Xiaofang
Feng, Yujie
Wei, Xiaoyue
Yu, Haijia
Wang, Yanting
Zhan, Yifan
Zhu, Xiangyang
Zhang, Xuemei
FRONTIERS IN IMMUNOLOGY, 2021, 12
[46] PD-L1 PET/CT imaging shows partial tumor saturation during atezolizumab treatment
Smit, L. M.
Hooiveld, J.
van de Donk, P. P.
de Ruijter, L. Kist
Kok, I. C.
Winkel, C. A. J.
Giesen, D.
Lub-de Hooge, M. N.
Brouwers, A. H.
Oosting, S. F.
Bensch, F.
Schroder, C. P.
Jalving, M.
Elias, S. G.
Gietema, J. A.
Deurloo, R. J.
Williams, S. P.
Ungewickell, A.
De Groot, D. J. A.
de Vries, E. G. E.
EUROPEAN JOURNAL OF CANCER, 2024, 211 : S100 - S100
[47] Evaluation of 64Cu-Labeled New Anti-EGFR Antibody NCAB001 with Intraperitoneal Injection for Early PET Diagnosis of Pancreatic Cancer in Orthotopic Tumor-Xenografted Mice and Nonhuman Primates
Matsumoto, Hiroki
Watabe, Tadashi
Igarashi, Chika
Tachibana, Tomoko
Hihara, Fukiko
Waki, Atsuo
Zhang, Ming-Rong
Tashima, Hideaki
Yamaya, Taiga
Ooe, Kazuhiro
Shimosegawa, Eku
Hatazawa, Jun
Yoshida, Sei
Naito, Kenichiro
Kurihara, Hiroaki
Ueno, Makoto
Ito, Kimiteru
Higashi, Tatsuya
Yoshii, Yukie
PHARMACEUTICALS, 2021, 14 (10)
[48] Pancreatic Neuroendocrine Tumor With Humoral Hypercalcemia and High Tumor PD-L1 Score
Copur, Mehmet Sitki
Vargas, Luciano
Wedel, Whitney
Merani, Shaheed
Cushman-Vokoun, Allison
Drincic, Angela
ONCOLOGY-NEW YORK, 2020, 34 (12): : 548 - 552
[49] 124I-Labeled Monoclonal Antibody and Fragment for the Noninvasive Evaluation of Tumor PD-L1 Expression In Vivo
Cheng, Yuan
Shi, Dai
Xu, Zhan
Gao, Zhihui
Si, Zhan
Zhao, Yanzhao
Ye, Renjie
Fu, Zhequan
Fu, Wenhui
Yang, Tingting
Xiu, Yan
Lin, Qingyu
Cheng, Dengfeng
MOLECULAR PHARMACEUTICS, 2022, : 3551 - 3562
[50] Immuno-PET Imaging of the Programmed Cell Death-1 Ligand (PD-L1) Using a Zirconium-89 Labeled Therapeutic Antibody, Avelumab
Jagoda, Elaine M.
Vasalatiy, Olga
Basuli, Falguni
Opina, Ana Christina L.
Williams, Mark R.
Wong, Karen
Lane, Kelly C.
Adler, Steve
Ton, Anita Thein
Szajek, Lawrence P.
Xu, Biying
Butcher, Donna
Edmondson, Elijah F.
Swenson, Rolf E.
Greiner, John
Gulley, James
Eary, Janet
Choyke, Peter L.
MOLECULAR IMAGING, 2019, 18

← 1 2 3 4 5 →